Nuvilex Appoints CEO And President Of Austrianova (Austria) To Scientific Advisory Board
3/11/2014 9:23:22 AM
SILVER SPRING, Md., March 11, 2014 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of deadly diseases, announced today that its subsidiary, Medical Marijuana Sciences, Inc., has appointed Brian Salmons, Ph.D., CEO and President of Nuvilex's partner Austrianova, to its Scientific Advisory Board.
Help employers find you! Check out all the jobs and post your resume.
comments powered by